Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00106600
Status:
COMPLETED
Last Update Posted:
2023-09-18
First Post:
2005-03-28
Brief Title:
Pixantrone BBR 2778 in Patients With Refractory Acute Myelogenous Leukemia AML
Sponsor:
CTI BioPharma
Organization:
CTI BioPharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-03
Completion Date Type:
None
First Submit Date:
2005-03-28
First Submit QC Date:
March 28 2005
Study First Post Date:
2005-03-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-14
Last Update Post Date:
2023-09-18
Last Update Post Date Type:
ACTUAL